NA Proactive news snapshot: Else Nutrition, Nextleaf Solutions, Tribe Property Technologies, TRACON Pharmaceuticals, Standard Uranium UPDATE …

Your daily round-up from the world of Proactive Else Nutrition Holdings Inc ( CVE:BABY ) (OTCMTKS:BABYF) (FRA:0YL) posted first-quarter results that saw its revenue rocket 282% year-over-year on the back of plant-based, non-diary, non-soy nutritional products. For the period ended March 31, 2021, the Israel-based food and nutrition company reported revenue of C$1,135,000, up from C$297,000 in the same quarter a year earlier. There was a 90% sequential growth in revenue from C$598,000 in the 4Q of 2020. During the 1Q, Else Nutrition clocked up formula revenue of C$862,000, up 149% from C$346,000 in the 4Q of 2020. Else had a strong cash position C$22,085,000 as of March 31, including restricted cash and short-term bank deposits.

Nextleaf Solutions Ltd ( CSE:OILS ) ( OTCQB:OILFF ) (FRA:L0MA) told shareholders that it had completed the second wholesale order from its recently announced customer, a Nasdaq-listed cannabis company. The Vancouver-based cannabis processor said […]

About the author: StockMan

Please remember:

The information provided here is for general knowledge and educational purposes only.
It is not intended to be a substitute for professional financial advice.
Every individual's financial situation is unique, and what works for one person may not work for another.
Before making any investment or financial decisions, you should always consult with a qualified financial advisor who understands your specific circumstances and goals.

Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, should never be acted upon. Please be aware that any information posted on this site should not be considered to be financial advice and i am not a financial advisor.

Posting Guidelines
  • Do contribute something to the discussion
  • Do post factual information, analysis and your view on company valuations
  • Do disclose if you have an interest in a security
  • Do take our Terms of Use seriously
Do Not
  • Do not make low-content posts, unsubstantiated ramps or untruthful/misleading statements
  • Do not complain about a post unless you have reported it first, and not on the forum.
  • Do not post financial advice
  • Do not advertise or post sponsored content

Get involved!

Get Connected!

Come and join our community. Expand your network and get to know new people!


No comments yet